D. Gail McCarver - Publications, H-index & Citations

D. Gail McCarver

medical college of wisconsin

24H指数

50论文数

2.7K被引数

收录论文 14

发表时间

Human Hepatic UGT2B15 Developmental Expression

TOXICOLOGICAL SCIENCES

IF4.1

2014-09-12

OAAI

Divakaran, Karthika; Hines, Ronald N.; McCarver, D. Gail

Identification and functional analysis of a novel human CYP2E1 far upstream enhancer

MOLECULAR PHARMACOLOGY

IF3

2007-06-01

PREAI

Shadley, Jeff D.; Divakaran, Karthika; Munson, Kimber; Hines, Ronald N.; Douglas, Kirk; McCarver, D. Gail

The effect of CYP2D6 polymorphisms on the response to pain treatment for pediatric sickle cell pain crisis

JOURNAL OF PEDIATRICS

IF3.5

2007-06-01

OAAI

Brousseau, David C.; McCarver, D. Gail; Drendel, Amy L.; Divakaran, Karthika; Panepinto, Julie A.

Cytochrome P4502D6 (CYP2D6) gene locus heterogeneity:: Characterization of gene duplication events

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2007-02-01

134

PREAI

Gaedigk, A.; Ndjountche, L.; Divakaran, K.; Bradford, L. DiAnne; Zineh, I.; Oberlander, T. F.; Brousseau, D. C.; McCarver, D. G.; Johnson, J. A.; Alander, S. W.; Riggs, K. Wayne; Leeder, J. Steven

Modeling interchild differences in pharmacokinetics on the basis of subject-specific data on physiology and hepatic CYP2E1 levels: A case study with toluene

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2006-07-01

PREAI

Nong, A.; McCarver, D. G.; Hines, R. N.; Krishnan, K.

Discovery of novel flavin-containing monooxygenase 3 (FMO3) single nucleotide polymorphisms and functional analysis of upstream haplotype variants

MOLECULAR PHARMACOLOGY

IF3

2005-08-01

PREAI

Koukouritaki, SB; Poch, MT; Cabacungan, ET; McCarver, DG; Hines, RN

Developmental expression of human hepatic CYP2C9 and CYP2C19

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2004-03-01

269

PREAI

Koukouritaki, SB; Manro, JR; Marsh, SA; Stevens, JC; Rettie, AE; McCarver, DG; Hines, RN

Genetic variability at the human FMO1 locus:: Significance of a basal promoter Yin Yang 1 element polymorphism (FMO1*6)

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2003-09-01

PREAI

Hines, RN; Luo, ZH; Hopp, KA; Cabacungan, ET; Koukouritaki, SB; McCarver, DG

Genotyping and site-directed mutagenesis of a cytochrome P450 meander Pro-X-Arg motif critical to CYP4B1 catalysis

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2003-01-01

PREAI

Zheng, YM; Henne, KR; Charmley, P; Kim, RB; McCarver, DG; Cabacungan, ET; Hines, RN; Rettie, AE

The ontogeny of human drug-metabolizing enzymes: Phase II conjugation enzymes and regulatory mechanisms

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2002-02-01

281

PREAI

McCarver, DG; Hines, RN

The ontogeny of human drug-metabolizing enzymes: Phase I oxidative enzymes

JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

IF3.8

2002-02-01

286

PREAI

Hines, RN; McCarver, DG

Ethnic differences in human flavin-containing monooxygenase 2 (FMO2) polymorphisms:: Detection of expressed protein in African-America

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

2000-11-01

PREAI

Whetstine, JR; Yueh, MF; Hopp, KA; McCarver, DG; Williams, DE; Park, CS; Kang, JH; Cha, YN; Dolphin, CT; Shephard, EA; Phillips, IR; Hines, RN

Ethnic differences of FMO3 gene mutant alleles.

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

1999-02-01

PREAI

Kang, JH; Park, CS; Lee, KH; Chung, WG; Baek, HM; Roh, HK; Cha, YN; McCarver, DG; Whestine, JR; Hines, RN

A genetic polymorphism in the regulatory sequences of human CYP2E1:: Association with increased chlorzoxazone hydroxylation in the presence of obesity and ethanol intake

TOXICOLOGY AND APPLIED PHARMACOLOGY

IF3.4

1998-09-01

139

PREAI

McCarver, DG; Byun, R; Hines, RN; Hichme, M; Wegenek, W

研究方向